{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:55:57Z","timestamp":1790009757835,"version":"4.0.1"},"reference-count":124,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP14066A"],"award-info":[{"award-number":["GGP14066A"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Disorders of lipid metabolism affect several tissues, including skeletal and cardiac muscle tissues. Lipid myopathies (LM) are rare multi-systemic diseases, which most often are due to genetic defects. Clinically, LM can have acute or chronic clinical presentation. Disease onset can occur in all ages, from early stages of life to late-adult onset, showing with a wide spectrum of clinical symptoms. Muscular involvement can be fluctuant or stable and can manifest as fatigue, exercise intolerance and muscular weakness. Muscular atrophy is rarely present. Acute muscular exacerbations, resulting in rhabdomyolysis crisis are triggered by several factors. Several classifications of lipid myopathies have been proposed, based on clinical involvement, biochemical defect or histopathological findings. Herein, we propose a full revision of all the main clinical entities of lipid metabolism disorders with a muscle involvement, also including some those disorders of fatty acid oxidation (FAO) with muscular symptoms not included among previous lipid myopathies classifications.<\/jats:p>","DOI":"10.3390\/jcm7120472","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T03:41:31Z","timestamp":1542944491000},"page":"472","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Lipid Myopathies"],"prefix":"10.3390","volume":"7","author":[{"given":"Elena Maria","family":"Pennisi","sequence":"first","affiliation":[{"name":"Unit of Neuromuscular Disorders, Neurology, San Filippo Neri Hospital, 00135 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1830-2886","authenticated-orcid":false,"given":"Matteo","family":"Garibaldi","sequence":"additional","affiliation":[{"name":"Unit of Neuromuscular Diseases, Department of Neurology, Mental Health and Sensory Organs (NESMOS), SAPIENZA University of Rome, Sant\u2019 Andrea Hospital, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Antonini","sequence":"additional","affiliation":[{"name":"Unit of Neuromuscular Diseases, Department of Neurology, Mental Health and Sensory Organs (NESMOS), SAPIENZA University of Rome, Sant\u2019 Andrea Hospital, 00189 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"40369","DOI":"10.1074\/jbc.R100050200","article-title":"The enzymes of neutral lipid synthesis","volume":"276","author":"Buhman","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.plipres.2010.10.004","article-title":"Lipolysis\u2014A highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores","volume":"50","author":"Lass","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11910-010-0154-y","article-title":"Lipid storage myopathy","volume":"11","author":"Liang","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/WCO.0000000000000483","article-title":"Update on diagnostics of metabolic myopathies","volume":"30","author":"Toscano","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2010.06.018","article-title":"Disorders of muscle lipid metabolism: Diagnostic and therapeutic challenges","volume":"20","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mus.24477","article-title":"A myopathy with unusual features caused by PNPLA2 gene mutations","volume":"51","author":"Pennisi","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ymgme.2012.12.004","article-title":"Neutral lipid storage disease with myopathy: A whole-body nuclear MRI and metabolic study","volume":"108","author":"Stojkovic","year":"2013","journal-title":"Mol. Genet. MeTable"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s00415-017-8498-8","article-title":"Muscle MRI in neutral lipid storage disease (NLSD)","volume":"264","author":"Garibaldi","year":"2017","journal-title":"J. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.nmd.2017.08.004","article-title":"Fatty acid oxidation defects presenting as primary myopathy and prominent dropped head syndrome","volume":"27","author":"Vengalil","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10545-013-9666-3","article-title":"Muscle MRI in patients with long-chain fatty acid oxidation disorders","volume":"37","author":"Diekman","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/WCO.0b013e32830dd5a6","article-title":"Lipid storage myopathies","volume":"21","author":"Bruno","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1203\/00006450-199009000-00020","article-title":"Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy","volume":"28","author":"Tein","year":"1990","journal-title":"Pediatr. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.179.4076.899","article-title":"Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: A new syndrome","volume":"179","author":"Engel","year":"1973","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/5030","article-title":"Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter","volume":"21","author":"Nezu","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/8.12.2247","article-title":"Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency","volume":"8","author":"Koizumi","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/humu.21607","article-title":"Genotype-phenotype correlation in primary carnitine deficiency","volume":"33","author":"Rose","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_17","unstructured":"(2018, August 27). Novel OCTN2 Mutations: No Genotype-Phenotype Correlations: Early Carnitine Therapy Prevents Cardiomyopathy, Available online: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Novel+OCTN2+mutations%3A+no+genotype-phenotype+correlations%3A+early+carnitine+therapy+prevents+cardiomyopathy."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mus.21167","article-title":"Clinical and genetic analysis of lipid storage myopathies","volume":"39","author":"Ohkuma","year":"2009","journal-title":"Muscle Nerve"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Tein, I. (2015). Lipid storage myopathies due to fatty acid oxidation defects. Neuromuscular Disorders of Infancy, Childhood, and Adolescence, Elsevier.","DOI":"10.1016\/B978-0-12-417044-5.00040-8"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajmg.10585","article-title":"Novel OCTN2 mutations: No genotype-phenotype correlations: Early carnitine therapy prevents cardiomyopathy","volume":"111","author":"Lamhonwah","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/324121","article-title":"Mutations in CGI-58, the gene encoding a new protein of the esterase\/lipase\/thioesterase subfamily, in Chanarin-Dorfman syndrome","volume":"69","author":"Jobard","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Coassin, S., Schweiger, M., Kloss-Brandst\u00e4tter, A., Lamina, C., Haun, M., Erhart, G., Paulweber, B., Rahman, Y., Olpin, S., and Wolinski, H. (2010). Investigation and functional characterization of rare genetic variants in the adipose triglyceride lipase in a large healthy working population. PLoS Genet., 6.","DOI":"10.1371\/journal.pgen.1001239"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMc0805305","article-title":"Triglyceride deposit cardiomyovasculopathy","volume":"359","author":"Hirano","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijcard.2015.05.004","article-title":"Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase","volume":"192","author":"Higashi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13023-017-0646-9","article-title":"Italian NLSD group neutral lipid storage diseases: Clinical\/genetic features and natural history in a large cohort of Italian patients","volume":"12","author":"Pennisi","year":"2017","journal-title":"Orphanet J. Rare. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.0954-6820.1953.tb07038.x","article-title":"The familial occurrence of fat containing vacuoles in the leukocytes diagnosed in two brothers suffering from dystrophia musculorum progressiva (ERB.)","volume":"145","author":"Jordans","year":"1953","journal-title":"Acta Med. Scand."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1212\/WNL.32.10.1106","article-title":"Successful treatment of familial idiopathic lipid storage myopathy with L-carnitine and modified lipid diet","volume":"32","author":"Snyder","year":"1982","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nm.2439","article-title":"ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-\u03b1 and PGC-1","volume":"17","author":"Haemmerle","year":"2011","journal-title":"Nat. Med."},{"key":"ref_30","first-page":"e51","article-title":"Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy","volume":"112","author":"Havekes","year":"2013","journal-title":"Circ. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"47066","DOI":"10.1074\/jbc.M403855200","article-title":"Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: Ectopic expression of desnutrin increases triglyceride hydrolysis","volume":"279","author":"Villena","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10545-014-9767-7","article-title":"Inborn errors of cytoplasmic triglyceride metabolism","volume":"38","author":"Wu","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.bbadis.2013.07.021","article-title":"Combination of lipid metabolism alterations and their sensitivity to inflammatory cytokines in human lipin-1-deficient myoblasts","volume":"1832","author":"Michot","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/8904_2015_440","article-title":"Rhabdomyolysis-Associated mutations in human LPIN1 lead to loss of phosphatidic acid phosphohydrolase activity","volume":"23","author":"Schweitzer","year":"2015","journal-title":"JIMD Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jpeds.2012.02.033","article-title":"Fatal rhabdomyolysis in 2 children with LPIN1 mutations","volume":"160","author":"Bergounioux","year":"2012","journal-title":"J. Pediatr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mus.24749","article-title":"A novel therapeutic approach for LPIN1 mutation-associated rhabdomyolysis\u2014The Austrian experience","volume":"52","author":"Pichler","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.182.4115.929","article-title":"Muscle carnitine palmityltransferase deficiency and myoglobinuria","volume":"182","author":"DiMauro","year":"1973","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajmg.c.30087","article-title":"Disorders of carnitine transport and the carnitine cycle","volume":"142C","author":"Longo","year":"2006","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1212\/01.WNL.0000055901.58642.48","article-title":"Carnitine palmitoyltransferase II deficiency: Molecular and biochemical analysis of 32 patients","volume":"60","author":"Wieser","year":"2003","journal-title":"Neurology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2013.12.026","article-title":"Carnitine palmitoyltransferase II (CPT II) deficiency: Genotype-phenotype analysis of 50 patients","volume":"338","author":"Joshi","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_41","first-page":"627","article-title":"Reversible asphyxial status in a newborn due to neonatal form of carnitine palmitoyltransferase II deficiency","volume":"29","author":"Brucknerova","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymgme.2017.07.011","article-title":"Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)\/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity","volume":"122","author":"Tajima","year":"2017","journal-title":"Mol. Genet. MeTable"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00508-012-0296-9","article-title":"Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency","volume":"124","author":"Joshi","year":"2012","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.WNL.0000078195.05396.20","article-title":"Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency","volume":"61","author":"Ejstrup","year":"2003","journal-title":"Neurology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.0000000000000118","article-title":"Bezafibrate in skeletal muscle fatty acid oxidation disorders: A randomized clinical trial","volume":"82","author":"Madsen","year":"2014","journal-title":"Neurology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/302261","article-title":"Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency","volume":"64","author":"Andresen","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01799421","article-title":"The mutational spectrum in very long-chain acyl-CoA dehydrogenase deficiency","volume":"19","author":"Andresen","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1203\/00006450-199307000-00025","article-title":"Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency","volume":"34","author":"Yamaguchi","year":"1993","journal-title":"Pediatr. Res."},{"key":"ref_49","first-page":"1165","article-title":"Disorders of fatty acid oxidation","volume":"113","author":"Tein","year":"2013","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nmd.2009.02.007","article-title":"Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency","volume":"19","author":"Rigal","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0009-8981(97)00185-X","article-title":"Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: Clinical characteristics and diagnostic considerations in 30 patients","volume":"269","author":"Divry","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/8904_2017_40","article-title":"Four years\u2019 experience in the diagnosis of very long-chain Acyl-CoA dehydrogenase deficiency in infants detected in three Spanish newborn screening centers","volume":"Volume 39","author":"Morava","year":"2017","journal-title":"JIMD Reports"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1172\/JCI0215311","article-title":"Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride","volume":"110","author":"Roe","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/mt.2012.39","article-title":"Long-term correction of very long-chain Acyl-CoA dehydrogenase deficiency in mice using AAV9 gene therapy","volume":"20","author":"Keeler","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00239-009-9263-0","article-title":"Acyl-CoA dehydrogenases: Dynamic history of protein family evolution","volume":"69","author":"Mohsen","year":"2009","journal-title":"J. Mol. Evol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1086\/519219","article-title":"A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency","volume":"81","author":"He","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.706","article-title":"Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency","volume":"42","author":"Haack","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13023-018-0784-8","article-title":"Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: Is riboflavin supplementation effective?","volume":"13","author":"Repp","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/brain\/awq273","article-title":"Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: New function for an old gene","volume":"134","author":"Gerards","year":"2011","journal-title":"Brain"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ymgme.2012.03.018","article-title":"MCAD deficiency in Denmark","volume":"106","author":"Andresen","year":"2012","journal-title":"Mol. Genet. MeTable"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1203\/00006450-199505000-00021","article-title":"Medium chain Acyl-CoA dehydrogenase deficiency in Pennsylvania: Neonatal screening shows high incidence and unexpected mutation frequencies","volume":"37","author":"Ziadeh","year":"1995","journal-title":"Pediatr. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10545-006-0292-1","article-title":"Newborn screening for medium-chain Acyl-CoA dehydrogenase deficiency: A global perspective","volume":"29","author":"Rhead","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ymgme.2016.10.007","article-title":"Screening of MCAD deficiency in Japan: 16 Years\u2019 experience of enzymatic and genetic evaluation","volume":"119","author":"Tajima","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s10545-006-0488-4","article-title":"Late presentation of medium-chain Acyl-CoA dehydrogenase deficiency","volume":"30","author":"Mayell","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_65","first-page":"291","article-title":"Medium-chain Acyl-CoA dehydrogenase deficiency","volume":"321","author":"Stanley","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1023\/A:1005676600975","article-title":"The HELLP syndrome associated wiht fetal medium-chain Acyl-CoA dehydrogenase deficiency","volume":"23","author":"Nelson","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1203\/00006450-200001000-00010","article-title":"Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy","volume":"47","author":"Innes","year":"2000","journal-title":"Pediatr. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1067\/mpd.2001.111814","article-title":"Acute fatty liver of pregnancy associated with short-chain acyl-coenzyme A dehydrogenase deficiency","volume":"138","author":"Matern","year":"2001","journal-title":"J. Pediatr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF01800712","article-title":"Medium-chain acyl-CoA dehydrogenase deficiency: Metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation","volume":"12","author":"Treem","year":"1989","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-3476(86)80762-4","article-title":"Recognition of medium-chain Acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes","volume":"108","author":"Roe","year":"1986","journal-title":"J. Pediatr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-3476(95)70207-5","article-title":"Clinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiency","volume":"126","author":"Bhala","year":"1995","journal-title":"J. Pediatr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.52.2.366","article-title":"Short-chain Acyl-CoA dehydrogenase deficiency: A cause of ophthalmoplegia and multicore myopathy","volume":"52","author":"Tein","year":"1999","journal-title":"Neurology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s004310050819","article-title":"Mild or absent clinical signs in twin sisters with short-chain Acyl-CoA dehydrogenase deficiency","volume":"157","author":"Ribes","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00439-008-0521-9","article-title":"The ACADS gene variation spectrum in 114 patients with short-chain Acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level","volume":"124","author":"Pedersen","year":"2008","journal-title":"Hum. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/hmg\/7.4.619","article-title":"Identification of four new mutations in the short-chain Acyl-CoA dehydrogenase (SCAD) gene in two patients: One of the variant alleles, 511C-->T, is present at an unexpectedly high frequency in the general population, as was the case for 625G-->A, together conferring susceptibility to ethylmalonic aciduria","volume":"7","author":"Gregersen","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.bbapap.2008.06.018","article-title":"Characterization of mitochondrial trifunctional protein and its inactivation study for medicine development","volume":"1784","author":"Liu","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1023\/A:1005504223140","article-title":"Disorders of mitochondrial fatty acyl-CoA beta-oxidation","volume":"22","author":"Wanders","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_78","first-page":"19","article-title":"Peroxisomal and mitochondrial enzymes","volume":"375","author":"Hashimoto","year":"1992","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1172\/JCI117158","article-title":"Mitochondrial trifunctional protein deficiency. Catalytic heterogeneity of the mutant enzyme in two patients","volume":"93","author":"Kamijo","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1172\/JCI115983","article-title":"Combined enzyme defect of mitochondrial fatty acid oxidation","volume":"90","author":"Jackson","year":"1992","journal-title":"J. Clin. Invest."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.physiol.64.082201.154705","article-title":"Fatty acid oxidation disorders","volume":"64","author":"Rinaldo","year":"2002","journal-title":"Annu. Rev. Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10545-005-0533-8","article-title":"Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency","volume":"28","author":"Olpin","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF01963564","article-title":"3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: Protective effect of medium-chain triglyceride treatment","volume":"150","author":"Duran","year":"1991","journal-title":"Eur. J. Pediatr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0140-6736(93)92993-4","article-title":"Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency","volume":"341","author":"Wilcken","year":"1993","journal-title":"Lancet"},{"key":"ref_85","first-page":"2293","article-title":"Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency","volume":"91","author":"Treem","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1203\/00006450-199012000-00023","article-title":"Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: A cause of lethal myopathy and cardiomyopathy in early childhood","volume":"28","author":"Rocchiccioli","year":"1990","journal-title":"Pediatr. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.10500","article-title":"Peripheral neuropathy, episodic myoglobinuria, and respiratory failure in deficiency of the mitochondrial trifunctional protein","volume":"29","author":"Spiekerkoetter","year":"2004","journal-title":"Muscle Nerve"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0887-8994(94)00100-G","article-title":"Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: Primary or secondary defect(s)?","volume":"12","author":"Tein","year":"1995","journal-title":"Pediatr. Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s004310050063","article-title":"Secondary respiratory chain defect in a boy with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Possible diagnostic pitfalls","volume":"159","author":"Das","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0960-8966(96)00352-5","article-title":"Pathology of skeletal muscle and impaired respiratory chain function in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency with the G1528C mutation","volume":"6","author":"Tyni","year":"1996","journal-title":"Neuromuscul. Disord."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1023\/A:1005502626406","article-title":"Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency","volume":"22","author":"Harding","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s10545-009-1125-9","article-title":"Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: Results from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.plipres.2005.12.002","article-title":"From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions","volume":"45","author":"Feige","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10545-008-0844-7","article-title":"PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders","volume":"31","author":"Djouadi","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1006\/bbrc.1996.0961","article-title":"Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: Cloning and characterization of the coding sequence","volume":"223","author":"Vredendaal","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1111\/j.1742-4658.2005.04911.x","article-title":"3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease","volume":"272","author":"Yang","year":"2005","journal-title":"FEBS J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410300315","article-title":"Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: A new cause for recurrent myoglobinuria and encephalopathy","volume":"30","author":"Tein","year":"1991","journal-title":"Ann. Neurol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1203\/00006450-199601000-00031","article-title":"Mitochondrial short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: A new defect of fatty acid oxidation","volume":"39","author":"Bennett","year":"1996","journal-title":"Pediatr. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s100249900132","article-title":"Fatal hepatic short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: Clinical, biochemical, and pathological studies on three subjects with this recently identified disorder of mitochondrial beta-oxidation","volume":"2","author":"Bennett","year":"1999","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/diabetes.53.1.221","article-title":"Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation","volume":"53","author":"Molven","year":"2004","journal-title":"Diabetes"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1203\/00006450-199711000-00002","article-title":"Medium chain 3-ketoacyl-coenzyme A thiolase deficiency: A new disorder of mitochondrial fatty acid beta-oxidation","volume":"42","author":"Kamijo","year":"1997","journal-title":"Pediatr. Res."},{"key":"ref_102","first-page":"567","article-title":"Human cDNA encoding ETF dehydrogenase (ETF: Ubiquinone oxido-reductase), and mutations in glutaric acidemia type II","volume":"375","author":"Goodman","year":"1992","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ajmg.1320320326","article-title":"Glutaric aciduria type II: Review of the phenotype and report of an unusual glomerulopathy","volume":"32","author":"Wilson","year":"1989","journal-title":"Am. J. Med. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Gr\u00fcnert, S.C. (2014). Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency. Orphanet J. Rare Dis., 9.","DOI":"10.1186\/s13023-014-0117-5"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neurol.2015.11.008","article-title":"Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease","volume":"172","author":"Souvannanorath","year":"2016","journal-title":"Rev. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ymgme.2007.09.015","article-title":"Risk of sudden death and acute life-threatening events in patients with glutaric acidemia type II","volume":"93","author":"Angle","year":"2008","journal-title":"Mol. Genet. MeTable"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00246-007-9119-6","article-title":"Cardiomyopathy in multiple Acyl-CoA dehydrogenase deficiency: A clinico-pathological correlation and review of literature","volume":"29","author":"Singla","year":"2008","journal-title":"Pediatr. Cardiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awm054","article-title":"The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene","volume":"130","author":"Gempel","year":"2007","journal-title":"Brain"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/humu.10226","article-title":"Clear relationship between ETF\/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency","volume":"22","author":"Olsen","year":"2003","journal-title":"Hum. Mutat."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1074\/jbc.M805719200","article-title":"Role of flavinylation in a mild variant of multiple acyl-CoA dehydrogenation deficiency: A molecular rationale for the effects of riboflavin supplementation","volume":"284","author":"Henriques","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awm135","article-title":"ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"130","author":"Olsen","year":"2007","journal-title":"Brain"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"E1976","DOI":"10.1002\/humu.21399","article-title":"Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric aciduria Type 2, is caused by a microdeletion in the riboflavin transporter gene GPR172B","volume":"32","author":"Ho","year":"2011","journal-title":"Hum. Mutat."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-010-9242-z","article-title":"Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: A new inborn error of metabolism with potential treatment","volume":"34","author":"Bosch","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10545-012-9513-y","article-title":"Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome","volume":"35","author":"Haack","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_115","unstructured":"(2018, August 28). SLC25A32 Mutations and Riboflavin-Responsive Exercise Intolerance, Available online: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26933868."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ajhg.2016.04.006","article-title":"Riboflavin-Responsive and -Non-responsive mutations in FAD synthase cause multiple Acyl-CoA dehydrogenase and combined respiratory-chain deficiency","volume":"98","author":"Olsen","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"E274","DOI":"10.1152\/ajpendo.00391.2001","article-title":"Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy","volume":"284","author":"Luzi","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. MeTable"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Lindegaard, B., Hvid, T., Wolsk Mygind, H., Mortensen, O.H., Gr\u00f8ndal, T., Abildgaard, J., Gerstoft, J., Pedersen, B.K., and Baranowski, M. (2018). Low expression of IL-18 and IL-18 receptor in human skeletal muscle is associated with systemic and intramuscular lipid metabolism-Role of HIV lipodystrophy. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196241"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/mus.20168","article-title":"Effects of alcohol on skeletal and cardiac muscle","volume":"30","year":"2004","journal-title":"Muscle Nerve"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1024842817060","article-title":"The importance of alcohol-induced muscle disease","volume":"24","author":"Preedy","year":"2003","journal-title":"J. Muscle Res. Cell. Motil."},{"key":"ref_121","first-page":"2023","article-title":"Natural history of alcoholic myopathy: A 5-year study","volume":"22","author":"Estruch","year":"1998","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/j.1530-0277.2007.00530.x","article-title":"Molecular and cellular events in alcohol-induced muscle disease","volume":"31","author":"Preedy","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/nu4081058","article-title":"Impaired insulin\/IGF signaling in experimental alcohol-related myopathy","volume":"4","author":"Nguyen","year":"2012","journal-title":"Nutrients"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnen\/nlx043","article-title":"Bortezomib-Induced Muscle Toxicity in Multiple Myeloma","volume":"76","author":"Guglielmi","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/7\/12\/472\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:31:34Z","timestamp":1760196694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/7\/12\/472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,23]]},"references-count":124,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["jcm7120472"],"URL":"https:\/\/doi.org\/10.3390\/jcm7120472","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,23]]}}}